|
| [ На главную ] -- [ Список участников ] -- [ Правила форума ] -- [ Зарегистрироваться ] |
| On-line: |
| Клуб болельщиков "Торпедо" Владимир / / gKSqYtpIfADhGHujR |
| Страницы: 1 |
|
| Автор | Сообщение |
|
Cyril Гость |
Добавлено: 16-08-2021 19:20 |
|
Excellent work, Nice Design minoxidil barba farmacia del ahorro Dr. Antoni Ribas at the University of California, LosAngeles says the immunotherapies are showing so much promisethat they, like Zelboraf, raise doubts over whether randomizedtrials are needed. He believes they could be approved in theUnited States on the basis of a single-arm trial. Yet Merck hasstarted enrolling patients in a study where patients will berandomized to get the new treatment or existing chemotherapy. |
| Страницы: 1 |
|
| Клуб болельщиков "Торпедо" Владимир / / gKSqYtpIfADhGHujR |